Continue to Site

Novartis to offer Ukraine-based humanitarian aid

By Brian Buntz | March 4, 2022

Novartis (NYSE:NVS) is joining a growing number of pharma companies in supporting humanitarian efforts in Ukraine.

The company recently announced an initial donation of $3 million to support Ukrainian humanitarian assistance initiatives at the International Red Cross and Red Crescent Movement, Save the Children and International Rescue Committee.

Bayer and Roche have announced similar initiatives.

Novartis also said it would offer ongoing financial support and donations of medicines to Ukrainians.

The company also criticized the war in a statement and pushed for a peaceful resolution.

Pharmacies in Ukraine have reported shortages of some medicines.

Novartis remains hopeful this war will reach a peaceful solution as soon as possible.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.